As part of the move to make clinical trial results more accessible, Elsevier is launching a new open access journal to provide an outlet for negative or less impactful trial … Continue Reading New journal will publish results from all scientifically sound clinical trials
In June, the Committee on Publication Ethics, the Directory of Open Access Journals, the Open Access Scholarly Publishers Association and the World Association of Medical Editors provided an update to … Continue Reading Principles of transparency and best practice in scholarly publishing
In a blog this week, the outcomes section editor for the journal Plastic and Reconstructive Surgery provides tips on how authors should address peer review comments and also what they … Continue Reading How to submit a manuscript revision and tips on being a good peer reviewer
A study was published in PLOS ONE this month to examine whether risk factors for scientific misconduct could predict the occurrence of retractions (which are usually the consequence of research … Continue Reading Misconduct policies, academic culture and career stage affect scientific integrity
A Wiley blog this week discusses the potential pitfalls associated with Altmetrics, including “the misappropriation of the term impact, the narrow scope of focus, and the potential goal displacement of … Continue Reading Challenges associated with #altmetrics: “attention is not impact”
As one of a number of changes designed to make the journal more patient-centered, The BMJ announced in 2014 that it would recruit patients to peer review research articles. In … Continue Reading The potential benefits of patient peer review
Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials
A study published in June in Current Medical Research and Opinion assessed the timely disclosure of results of company-sponsored clinical trials related to all new medicines approved by the European … Continue Reading Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials
2015 Asia Pacific publication meetings: “Collaborating for Ethical and Effective Publication Practices”
Medical publications from the Asia Pacific region are increasing… and coming under intense scrutiny. Proven and practical solutions for enhancing the speed, quality, and influence of these publication will be … Continue Reading 2015 Asia Pacific publication meetings: “Collaborating for Ethical and Effective Publication Practices”
A recent blog by the London School for Economics and Political Science provides an interesting commentary on the importance and relevance of authorship decisions. The blog also provides several useful … Continue Reading Recommendations for deciding who gets authorship credit.
New approaches to assessing medical publication impact in social media: Altmetric, Plum Analytics, and Augmented Reality
This poster was presented at the recent DIA 2015 meeting in Washington DC. To access the PDF of the article, then please click here.
The following video on clinical trial data sharing was presented at the DIA 2015 51st Annual Meeting.
In the past few days, the New York Times has published an article about the recent increase in the retraction of papers from journals. The article is focused on the … Continue Reading Retractions: science under scrutiny
The scientific publishing community is currently awaiting the announcements on new journal impact factors. With this in mind, a post-doc researcher has written a BioMed Central blog this week that … Continue Reading Impact factors and academic careers: insights from a postdoc perspective
An editorial in the BMJ this week discusses some of the harms associated with selective clinical trial reporting… specifically relating to trials of cardiovascular devices. To support the points made … Continue Reading BMJ Editorial: “Selective clinical trial reporting: betraying trial participants, harming patients”